angiotensin ii has been researched along with 4-hydroxy-2-nonenal in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T | 1 |
| Jankowski, M; Liu, J; Pagano, PJ; Yang, F; Yang, XP | 1 |
| Liu, J; Oja-Tebbe, N; Ormsby, A; Pagano, PJ | 1 |
| Inoguchi, T; Kobayashi, K; Maeda, Y; Nakayama, M; Nawata, H; Sasaki, S; Sawada, F; Sonoda, N; Sonta, T; Sumimoto, H; Tsubouchi, H | 1 |
| Ishizaka, N; Matsuzaki, G; Mori, I; Nagai, R; Ohno, M; Saito, K | 1 |
| Clark, SE; Ferrario, CM; Li, W; Sowers, JR; Stump, CS; Wei, Y | 1 |
| Avila-Casado, C; Franco, M; Johnson, RJ; Nakagawa, T; Rodríguez-Iturbe, B; Sánchez-Lozada, LG; Sautin, YY; Soto, V; Tapia, E | 1 |
| Kobori, H; Ohashi, N; Urushihara, M | 1 |
| Hayashi, T; Jin, D; Kitada, K; Kitaura, Y; Matsumoto, C; Matsumura, Y; Miyamura, M; Miyazaki, M; Mori, T; Ohkita, M; Okada, Y; Takai, S; Ukimura, A; Yamashita, C | 1 |
| Goto, T; Lee, SH; Oe, T; Takahashi, R | 1 |
| Inoue, T; Kikumoto, Y; Makino, H; Sugiyama, H; Takiue, K; Uchida, HA | 1 |
| Borović-Šunjić, S; Bozorg Grayeli, A; Ferrary, E; Milković, L; Rudić, M; Sterkers, O; Waeg, G; Žarković, K; Žarković, N | 1 |
| Lee, SH | 1 |
| Azuma, K; Azushima, K; Dejima, T; Kanaoka, T; Kobayashi, R; Maeda, A; Matsuda, M; Ohsawa, M; Tamura, K; Umemura, S; Uneda, K; Wakui, H; Yamashita, A | 1 |
| Fei, L; Jianting, D; Jiewen, L; Li, F; Liting, Z; Xuansheng, H; Yi, L; Yong, Y | 1 |
| Conte, D; Minas, JN; Nishiyama, A; Ortiz, RM; Thorwald, MA; Vázquez-Medina, JP | 1 |
| Cartland, SP; Dang, L; Kavurma, MM; Manuneedhi Cholan, P; Patel, S; Rayner, BS; Thomas, SR | 1 |
| Fujioka, S; Lee, SH; Oe, T; Takahashi, R | 1 |
| Palaniyandi, SS; Roy, B | 1 |
2 review(s) available for angiotensin ii and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.
Topics: Aldehydes; Angiotensin II; Angiotensinogen; Animals; Biomarkers; Cysteine Proteinase Inhibitors; Evidence-Based Medicine; Glomerulonephritis, IGA; Heme Oxygenase-1; Humans; Mice; Reactive Oxygen Species; Renin-Angiotensin System; Vasoconstrictor Agents | 2009 |
[Oxidative stress-mediated chemical modifications to biomacromolecules: mechanism and implication of modifications to human skin keratins and angiotensin II].
Topics: Aldehydes; Angiotensin II; Animals; Aspartic Acid; Cardiovascular Diseases; DNA; DNA Damage; Glutamyl Aminopeptidase; Humans; Keratins; Lipid Peroxides; Mass Spectrometry; Methionine; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 2; Skin | 2013 |
17 other study(ies) available for angiotensin ii and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cell Division; Cells, Cultured; DNA; Drug Synergism; Flavonoids; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Probucol; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tyrphostins | 2001 |
NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy.
Topics: Aldehydes; Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Chemotaxis, Leukocyte; Enzyme Inhibitors; Gene Expression Regulation; Glycoproteins; Hypertrophy; Intercellular Adhesion Molecule-1; Macrophages; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Single-Blind Method; Tunica Intima; Tunica Media; Vasculitis | 2003 |
Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy.
Topics: Adenoviridae; Aldehydes; Angiotensin II; Animals; Blood Pressure; Carotid Arteries; Defective Viruses; Genes, Reporter; Genetic Therapy; Genetic Vectors; Glycoproteins; Hypertrophy; Injections, Intra-Arterial; Lipid Peroxidation; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Reactive Oxygen Species; Tunica Media | 2004 |
Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Body Weight; Deoxyguanosine; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin; Islets of Langerhans; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Tetrazoles; Time Factors; Valine; Valsartan | 2005 |
Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats.
Topics: Aldehydes; Angiotensin II; Animals; Aorta; Aortic Diseases; Apoferritins; Chemokine CCL2; Deferoxamine; Ferritins; Heme Oxygenase-1; Hypertension; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; RNA, Messenger; Up-Regulation; Vasoconstrictor Agents; Vasodilation | 2005 |
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase.
Topics: Aldehydes; Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Glucose Transporter Type 4; Insulin Resistance; Male; Muscle, Skeletal; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transcription Factor RelA; Transfection; Tumor Necrosis Factor-alpha | 2008 |
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.
Topics: Aldehydes; Angiotensin II; Animals; Antioxidants; Arterioles; Body Weight; Cyclic N-Oxides; Disease Models, Animal; Glomerular Filtration Rate; Hypertension, Renal; Hyperuricemia; Kidney Glomerulus; Male; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Oxonic Acid; Rats; Rats, Sprague-Dawley; Renal Circulation; Spin Labels; Superoxides; Tyrosine | 2008 |
Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice.
Topics: Acetamides; Aldehydes; Angiotensin II; Animals; Body Weight; Chymases; Gene Expression; Hemodynamics; Hypoxia; Immunohistochemistry; Interleukin-6; Lipid Peroxides; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; NADP; Organ Size; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2009 |
Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal.
Topics: Aldehydes; Amino Acid Sequence; Angiotensin II; Borohydrides; Chromatography, High Pressure Liquid; Lipid Peroxidation; Oligopeptides; Oxidation-Reduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2010 |
Development of angiotensin II-induced abdominal aortic aneurysms is independent of catalase in mice.
Topics: Aldehydes; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Blood Pressure; Body Weight; Catalase; Cholesterol; Lipid Peroxidation; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Oxidative Stress | 2011 |
The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis.
Topics: Aldehydes; Angiotensin II; Apoptosis; Bone and Bones; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cysteine Proteinase Inhibitors; Humans; Osteoblasts; Otosclerosis; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2013 |
Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Topics: Adaptor Proteins, Signal Transducing; Aldehydes; Angiotensin II; Animals; Aorta; Cells, Cultured; Cytochrome b Group; Disease Models, Animal; Hypertension; Hypertrophy; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Transfection | 2013 |
Upregulation of sestrin-2 expression protects against endothelial toxicity of angiotensin II.
Topics: Aldehydes; Angiotensin II; Apoptosis; Cell Survival; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; JNK Mitogen-Activated Protein Kinases; L-Lactate Dehydrogenase; MAP Kinase Signaling System; Nuclear Proteins; Oxidative Stress; Promoter Regions, Genetic; Reactive Oxygen Species; RNA Interference; RNA, Messenger; RNA, Small Interfering; Up-Regulation; Vasoconstrictor Agents | 2014 |
Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Topics: Adrenal Glands; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Eplerenone; Heart Diseases; Hypertension; Lipid Peroxidation; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction; Spironolactone; Time Factors; Tyrosine | 2015 |
TRAIL protects against endothelial dysfunction in vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in vitro.
Topics: Aldehydes; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Endothelial Cells; Humans; Mice; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species; TNF-Related Apoptosis-Inducing Ligand; Vascular Cell Adhesion Molecule-1; Vasodilation | 2018 |
Angiotensin II-Induced Oxidative Stress in Human Endothelial Cells: Modification of Cellular Molecules through Lipid Peroxidation.
Topics: Aldehydes; Angiotensin II; Ascorbic Acid; Carbon Isotopes; Cell Line; Copper Sulfate; Endothelial Cells; Humans; Isotope Labeling; Linoleic Acid; Lipid Peroxidation; Oxidative Stress; Receptor, Angiotensin, Type 1 | 2019 |
A role for aldehyde dehydrogenase (ALDH) 2 in angiotensin II-mediated decrease in angiogenesis of coronary endothelial cells.
Topics: Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Angiogenesis Inhibitors; Angiotensin II; Cell Line; Coronary Vessels; Endothelial Cells; Neovascularization, Physiologic; Receptor, Angiotensin, Type 2; Signal Transduction; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2021 |